Tuberculosis Elimination and Implementation Science

Tuberculosis (TB) is the world’s leading infectious disease killer. Drug-resistant TB (DR-TB) is an urgent threat to global and individual health security.

We're contributing towards global targets to eliminate TB as a public health threat through partnerships, community engagement, technical assistance to national programs and implementation of innovation and research.

To eliminate tuberculosis, it's critical to first address drug-resistant tuberculosis as a crisis and threat to global health security. Our focus is on the Asia-Pacific region, which carries most of the global tuberculosis burden. Utilising our breadth and depth in research, international development and public health, we're providing support to national tuberculosis programs to strengthen health systems, design and evaluate programs and build capacity for operational research.

Papua New Guinea has been increasingly recognised as a hotspot for tuberculosis and drug-resistance. The RID-TB project continues to make significant progress towards combatting the major drug-resistant tuberculosis outbreak on Daru Island in the Western Province, which has rates that are among the highest reported globally.

Burnet Institute is a key technical partner in the Papua New Guinea government's emergency response to drug-resistant tuberculosis, working in collaboration with partners funded by the Australian Government, including World Vision.